Importing Nutraceutical Ingredients from China: Regulatory Guide for FDA, EU, and APAC

Why This Guide Exists

China supplies over 70% of the global bulk nutraceutical ingredient market. For US, EU, and APAC buyers, sourcing from China is cost-effective — but navigating the regulatory and logistics requirements can be opaque. This guide consolidates the documentation checklist, common pitfalls, and best practices from our experience shipping to 50+ countries.

Core Documents Required for Every Shipment

1. Certificate of Analysis (COA) — issued by the manufacturer; ideally backed by third-party ISO 17025-accredited lab. Must include lot number, manufacturing date, expiry, and all test parameters with results and specification limits.
2. Material Safety Data Sheet (MSDS/SDS) — required by customs in most jurisdictions. Should conform to GHS format.
3. Certificate of Origin (CO) — Form A (GSP) or regular CO issued by the China Council for the Promotion of International Trade (CCPIT) or local Chamber of Commerce. Required for tariff reduction in many markets.
4. Phytosanitary Certificate — required for plant-derived ingredients in most markets. Issued by China's GACC (General Administration of Customs). Not required for synthetic/fermentation-derived molecules like NMN.
5. Technical Data Sheet (TDS) / Product Specification Sheet — detailed specifications including CAS number, IUPAC name, physical characteristics, and intended use.
6. Customs Invoice — must accurately state HS code, declared value, and ingredient description matching the COA.

US Import Requirements (FDA)

FSMA (Food Safety Modernization Act) compliance: Foreign suppliers must either be registered under FSVP (Foreign Supplier Verification Program) or provide documentation that their facility has been assessed. Key documents:

• FDA Facility Registration number (required for food/supplement ingredient exporters under FSMA)
• FSVP-ready documentation package (hazard analysis, supplier verification activities)
• Prior Notice: all food shipments to the US require electronic prior notice submission via FDA's PN system at least 2–8 hours before arrival at the port of entry

For dietary supplement ingredients: no FDA pre-market approval is required, but if the ingredient was not marketed in the US before October 15, 1994, a New Dietary Ingredient (NDI) notification must be filed 75 days before marketing. NMN, NRC, CDP-Choline, and S-Equol all have established precedents. NRHM as a salt of an established ingredient generally does not require a new NDI.

EU Import Requirements

Novel Food Regulation (EU) 2015/2283: An ingredient requires Novel Food authorization if it was not consumed to a significant degree in the EU before May 15, 1997. CDP-Choline and S-Equol may require Novel Food authorization depending on target application and dose.

• Health supplements: supervised by EFSA; country-specific notification (Germany BfR, France ANSES, etc.)
• Cosmetics: INCI listing and SCCS safety assessment required for new ingredients
• Pharma: full EMA dossier required; typically not pursued by raw material suppliers
• EU Customs: HS Code, EUR.1 or REX declaration for preferential origin; phytosanitary cert for plant materials

APAC Import Requirements

Key markets:

• Japan: Food ingredients must comply with the Food Sanitation Act. Functional ingredients for FFC labeling require notification via Consumer Affairs Agency (CAA). No pre-approval for non-pharmaceutical supplements.
• South Korea: Health Functional Food Act governs supplement ingredients. Most NAD⁺ precursors are registered under the individual recognition pathway.
• Australia/NZ: TGA (Therapeutic Goods) registration required for listed medicines (ARTG). COA and GMP certification from a TGA-recognized authority required for all listed ingredients.
• China domestic: For re-import or local distribution: Blue Hat (健字号) certification via NHSA required for health foods. Most PathGene ingredients are registered or registration-eligible.

Common Pitfalls and How to Avoid Them

• Incorrect HS code — can trigger seizure, delay, or duty reclassification. Work with a customs broker experienced in nutraceutical HS classification.
• Missing FDA registration number on commercial invoice — shipments without this are routinely detained at US ports.
• COA lot number mismatch — if the lot number on your COA does not match the packaging, expect detention.
• FSVP gap — US importers are responsible for FSVP compliance. Ensure your supplier can provide hazard analysis documentation.
• Phytosanitary cert for synthetic ingredients — many buyers incorrectly request this for synthetic NMN. NMN is chemically or enzymatically synthesized — a phytosanitary cert is not required and will cause delays at customs.

PathGene Export Documentation Support

PathGene provides a complete export documentation package with every commercial shipment, including: COA (third-party + in-house), MSDS/SDS, TDS, Certificate of Origin (CCPIT), packing list, commercial invoice with correct HS codes, and optional FDA facility registration letter. We have supported successful customs clearance in the US, Germany, Netherlands, UK, Japan, South Korea, Australia, and 40+ other markets. Contact us for a documentation sample package.